The First Psychedelic Medicine Clinic Opens in Minnesota
Marijuana Stocks, Finance, & InvestingUncategorized March 30, 2021 MJ Shareholders
ST. PAUL, Minn., March 29, 2021 /PRNewswire/ — The growing rates of depression, anxiety, and other mental health illnesses have contributed to a national mental health crisis in the United States and call for new and unconventional treatment options. Recent research around therapeutic psychedelics suggests that these powerful substances may hold tremendous power in addressing such an urgent public health epidemic.
The first psychedelic-assisted therapy clinic in Minnesota, called the Institute for Integrative Therapies (IIT), opens its new St. Paul clinic May 1st (after completing a soft opening that ran between July 2020-March 2021), laying a foundation for the coming psychedelic renaissance in the field of mental health. IIT’s aim is to help make the Midwest a hub for furthering this re-emergent field, through the delivery of psychedelic-therapies, research, public education and interdisciplinary community-building.
Psychedelic-Assisted Therapy is actually not a new treatment, however due to the cultural revolution of the late 1960s, along with the failed war on drugs, this field froze over for several decades. Over the last 20 years, this field has slowly started warming, and is on the brink of reaching critical mass, on the precipice of breaking back into the mainstream. Currently, Ketamine is the only legal substance used for these therapies in most states, including the state of Minnesota.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers